Effectiveness of ICD therapy in real clinical practice. The
Olomouc ICD Registry

J 2023

Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry

TABORSKY, Milos, Tomas SKALA, Marian FEDORCO, Vlastimil DOUPAL, Ingrid SOVOVA et. al.

Základní údaje

Originální název

Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry

Autoři

TABORSKY, Milos (203 Česká republika), Tomas SKALA (203 Česká republika, garant), Marian FEDORCO (203 Česká republika), Vlastimil DOUPAL (203 Česká republika), Ingrid SOVOVA (203 Česká republika), Jiří JARKOVSKÝ (203 Česká republika, domácí), Klára BENEŠOVÁ (203 Česká republika, domácí), Monika BEZDEKOVA (203 Česká republika), Marek VICHA (203 Česká republika), Josef DANEK (203 Česká republika) a Josef KAUTZNER (203 Česká republika)

Vydání

Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2023, 1213-8118

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 0.900 v roce 2022

Kód RIV

RIV/00216224:14110/23:00129947

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.5507/bp.2021.071

UT WoS

000733638200001

Klíčová slova anglicky

implantable cardioverter-defibrillator; heart failure; primary prevention; time to shock; sppropriate shock; mortality

Štítky

14119612, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 26. 1. 2024 09:48, Mgr. Tereza Miškechová

Anotace

V originále

Background. Clinical parameters linked to a low benefit of ICD implantation and increased mortality risks are needed for an individualized assessment of potential benefits and risks of ICD implantation. Methods. Analysis of a prospective registry of all patients hospitalized from 2009 to 2019 in a single centre for a first Results. A total of 2,681 patients were included in the registry. Until the end of follow-up (38.4 +/- 29.1 months), 682 (25.4%) patients died. The one-year mortality in all patients, the one-year CV mortality, the three-year mortality in all patients, and the three-year CV mortality were 7.8%, 5.7%, 20.6%, and 14.8%, respectively. There was a statistically significant difference when the subgroups were compared according to the type of cardiomyopathy. No significant difference was found between primary and secondary prevention and between the types of devices. Male gender, age >= 75 years, diabetes mellitus, and atrial fibrillation were associated with a significantly increased mortality risk. Conclusion. In an analysis of a long-term follow-up of 2,681 ICD patients, we found no mortality difference between patients with ischemic or non-ischemic cardiomyopathy and in the device type. A higher mortality risk was found in men, patients older than 75 years, diabetics, and those with atrial fibrillation.

Citovat

TABORSKY, Milos, Tomas SKALA, Marian FEDORCO, Vlastimil DOUPAL, Ingrid SOVOVA, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Monika BEZDEKOVA, Marek VICHA, Josef DANEK a Josef KAUTZNER. Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2023, roč. 167, č. 3, s. 225-235. ISSN 1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2021.071.

@article{1834303,
   author = {Taborsky, Milos and Skala, Tomas and Fedorco, Marian and Doupal, Vlastimil and Sovova, Ingrid and Jarkovský, Jiří and Benešová, Klára and Bezdekova, Monika and Vicha, Marek and Danek, Josef and Kautzner, Josef},
   article_location = {Olomouc},
   article_number = {3},
   doi = {http://dx.doi.org/10.5507/bp.2021.071},
   keywords = {implantable cardioverter-defibrillator; heart failure; primary prevention; time to shock; sppropriate shock; mortality},
   language = {eng},
   issn = {1213-8118},
   journal = {Biomedical Papers, Olomouc: Palacky University},
   title = {Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry},
   url = {https://biomed.papers.upol.cz/corproof.php?tartkey=bio-000000-3086},
   volume = {167},
   year = {2023}
}

TY  - JOUR
ID  - 1834303
AU  - Taborsky, Milos - Skala, Tomas - Fedorco, Marian - Doupal, Vlastimil - Sovova, Ingrid - Jarkovský, Jiří - Benešová, Klára - Bezdekova, Monika - Vicha, Marek - Danek, Josef - Kautzner, Josef
PY  - 2023
TI  - Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry
JF  - Biomedical Papers, Olomouc: Palacky University
VL  - 167
IS  - 3
SP  - 225-235
EP  - 225-235
PB  - Palacky University
SN  - 12138118
KW  - implantable cardioverter-defibrillator
KW  - heart failure
KW  - primary prevention
KW  - time to shock
KW  - sppropriate shock
KW  - mortality
UR  - https://biomed.papers.upol.cz/corproof.php?tartkey=bio-000000-3086
N2  - Background. Clinical parameters linked to a low benefit of ICD implantation and increased mortality risks are needed for an individualized assessment of potential benefits and risks of ICD implantation. Methods. Analysis of a prospective registry of all patients hospitalized from 2009 to 2019 in a single centre for a first Results. A total of 2,681 patients were included in the registry. Until the end of follow-up (38.4 +/- 29.1 months), 682 (25.4%) patients died. The one-year mortality in all patients, the one-year CV mortality, the three-year mortality in all patients, and the three-year CV mortality were 7.8%, 5.7%, 20.6%, and 14.8%, respectively. There was a statistically significant difference when the subgroups were compared according to the type of cardiomyopathy. No significant difference was found between primary and secondary prevention and between the types of devices. Male gender, age >= 75 years, diabetes mellitus, and atrial fibrillation were associated with a significantly increased mortality risk. Conclusion. In an analysis of a long-term follow-up of 2,681 ICD patients, we found no mortality difference between patients with ischemic or non-ischemic cardiomyopathy and in the device type. A higher mortality risk was found in men, patients older than 75 years, diabetics, and those with atrial fibrillation.
ER  -

TABORSKY, Milos, Tomas SKALA, Marian FEDORCO, Vlastimil DOUPAL, Ingrid SOVOVA, Jiří JARKOVSKÝ, Klára BENEŠOVÁ, Monika BEZDEKOVA, Marek VICHA, Josef DANEK a Josef KAUTZNER. Effectiveness of ICD therapy in real clinical practice. The Olomouc ICD Registry. \textit{Biomedical Papers, Olomouc: Palacky University}. Olomouc: Palacky University, 2023, roč.~167, č.~3, s.~225-235. ISSN~1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2021.071.

Podrobný výpis o publikaci